Quest Diagnostics and Proov have teamed up to introduce the company’s Confirm PdG test, an FDA-cleared PdG (progesterone metabolite) home test kit that confirms successful ovulation, through Questhealth.com. To date Questhealth.com has primarily offered laboratory test services provided by Quest Diagnostics. This collaboration marks the first time a women’s health test from a third-party manufacturer is available on the platform.
Progesterone is a reproductive hormone that helps prepare the lining of the uterus for implantation and pregnancy. Progesterone levels should be elevated several days after ovulation to allow implantation to occur, this is known as the implantation window. The Proov Confirm PdG test is intended for the detection of pregnanediol glucuronide (PdG, the major urine metabolite of progesterone) in urine and can be used as an aid for confirmation of ovulation. It measures PdG levels in the urine over four key days — the “implantation window” — to help assess if ovulation was successful.
Proov Founder and CEO, Amy Beckley, PhD shares: “I created Proov after my own battle with infertility because I wanted other women to have more information and options than what I had at the time,” said . “We are thrilled to collaborate with Quest to broaden access to Proov Confirm so even more women can access insights to help them realize their dream of raising a family.”
In addition to the Proov Confirm test, Questhealth.com offers other fertility assessment and family planning tests, such as the Ovarian Reserve Assessment Marker (AMH) Test, hCG Pregnancy Test, Pre-Pregnancy Test Panel, and Testosterone Test (Men).
